KBR Beats Q1 Adjusted EPS, Reaffirms Guidance, and Details Progress on Mission Technology Spin-Off

summarizeSummary

KBR reported strong first-quarter fiscal 2026 results, with adjusted EPS of $0.96 beating analyst estimates, and reaffirmed its full-year guidance while providing an update on the planned spin-off of its Mission Technology Solutions segment.

check_boxKey Events

• Q1 Adjusted EPS Beats Estimates

  KBR reported adjusted EPS of $0.96 for the first quarter fiscal 2026, significantly beating the IBES estimate of $0.91. Diluted EPS attributable to KBR was $0.80, down 9% year-over-year.

• Fiscal 2026 Guidance Reaffirmed

  The company reaffirmed its full-year fiscal 2026 outlook, projecting revenues between $7.90 billion and $8.36 billion, adjusted EBITDA between $980 million and $1.04 billion, and adjusted EPS between $3.87 and $4.22.

• Strategic Spin-Off Progress Detailed

  KBR reiterated its intent to spin off the Mission Technology Solutions segment into a separate public company, targeting completion on January 4, 2027, with perimeter changes implemented in fiscal 2026 to align businesses for the tax-free separation.

• Strong Bookings and Backlog

  Bookings and options for the quarter totaled $1.9 billion, resulting in a book-to-bill ratio of 1.1x. Total backlog and options stood at $23.2 billion as of April 3, 2026.

auto_awesomeAnalysis

KBR delivered a strong first quarter, with adjusted EPS significantly exceeding analyst expectations, which is a positive signal for investors. The company's decision to reaffirm its full-year fiscal 2026 guidance, despite a slight revenue decline attributed to expected EUCOM contingency runoff, indicates confidence in its operational execution and future outlook. The filing also provides a detailed update on the strategic spin-off of its Mission Technology Solutions segment, a major corporate event aimed at unlocking shareholder value, with a target completion date of January 4, 2027. Furthermore, substantial new contract awards across both segments, contributing to a healthy book-to-bill ratio and robust backlog, underscore the company's continued growth momentum and market position.